临床眼科杂志
臨床眼科雜誌
림상안과잡지
JOURNAL OF CLINICAL OPHTHALMOLOGY
2015年
3期
224-226
,共3页
复方樟柳碱%胰激肽原酶肠溶片%血管性假性视乳头炎%可行性%安全性
複方樟柳堿%胰激肽原酶腸溶片%血管性假性視乳頭炎%可行性%安全性
복방장류감%이격태원매장용편%혈관성가성시유두염%가행성%안전성
Compound anisodine%Pancreatic kininogenase enteric coated tablets%Vascular pseudo papillitis%Feasibility%safety
目的对复方樟柳碱联合降糖药物治疗血管性假性视乳头炎的可行性及依从性进行研究,为临床治疗提供指导。方法选取我院2013年3月至2014年3月间治疗的糖尿病伴血管性假性视乳头炎患者124例(124只眼)为研究对象,采用随机抽签的方式将其分为两组,每组62例。对照组研究对象予以复方樟柳碱治疗;观察组研究对象采用复方樟柳碱联合降糖药物阿卡波糖片进行治疗。治疗后就其疗效、安全性及治疗依从性进行组间比较。结果观察组研究对象的总有效率为90.3%高于对照组77.4%的总有效率,且具有显著差异性(P <0.05);观察组研究对象的不良反应发生率为12.9%低于对照组14.5%的不良反应率,但无显著差异性(P >0.05);在治疗依从性的比较中,两组研究对象均在90.0%以上,无显著差异性(P >0.05)。结论复方樟柳碱联合降糖药物用于血管性假性视乳头炎的治疗中具有疗效显著,安全性高,治疗依从性高等优势。
目的對複方樟柳堿聯閤降糖藥物治療血管性假性視乳頭炎的可行性及依從性進行研究,為臨床治療提供指導。方法選取我院2013年3月至2014年3月間治療的糖尿病伴血管性假性視乳頭炎患者124例(124隻眼)為研究對象,採用隨機抽籤的方式將其分為兩組,每組62例。對照組研究對象予以複方樟柳堿治療;觀察組研究對象採用複方樟柳堿聯閤降糖藥物阿卡波糖片進行治療。治療後就其療效、安全性及治療依從性進行組間比較。結果觀察組研究對象的總有效率為90.3%高于對照組77.4%的總有效率,且具有顯著差異性(P <0.05);觀察組研究對象的不良反應髮生率為12.9%低于對照組14.5%的不良反應率,但無顯著差異性(P >0.05);在治療依從性的比較中,兩組研究對象均在90.0%以上,無顯著差異性(P >0.05)。結論複方樟柳堿聯閤降糖藥物用于血管性假性視乳頭炎的治療中具有療效顯著,安全性高,治療依從性高等優勢。
목적대복방장류감연합강당약물치료혈관성가성시유두염적가행성급의종성진행연구,위림상치료제공지도。방법선취아원2013년3월지2014년3월간치료적당뇨병반혈관성가성시유두염환자124례(124지안)위연구대상,채용수궤추첨적방식장기분위량조,매조62례。대조조연구대상여이복방장류감치료;관찰조연구대상채용복방장류감연합강당약물아잡파당편진행치료。치료후취기료효、안전성급치료의종성진행조간비교。결과관찰조연구대상적총유효솔위90.3%고우대조조77.4%적총유효솔,차구유현저차이성(P <0.05);관찰조연구대상적불량반응발생솔위12.9%저우대조조14.5%적불량반응솔,단무현저차이성(P >0.05);재치료의종성적비교중,량조연구대상균재90.0%이상,무현저차이성(P >0.05)。결론복방장류감연합강당약물용우혈관성가성시유두염적치료중구유료효현저,안전성고,치료의종성고등우세。
Objective To study the feasibility and compliance of compound anisodine combined with acarbose for the treatment of vascular pseudo papillitis,and to provide guidance for clinical management. Methods The subjects of this study were 124 patients with diabetic vascular pseudo papillitis who were treated in our hospital between March 2013 and March 2014. Patients randomly received compound anisodine alone (control)or combined with acarbose (observation group). The efficacy,safety and compliance of the treatments were compared between the two groups. Results In the ob-servation group,the overall efficiency was 90. 3%,significantly higher than that of control group (77. 4%;P < 0. 05). Rate of adverse reaction was 12. 9%,lower than that of control group 14. 5% but did not reach statistical significance. Compliance were more than 90% in both groups and there was no difference between the two groups (P > 0. 05). Conclu-sion Compound anisodine combined with acarbose is an effective and safe treatment for vascular pseudo papillitis in dia-betic patients. This regimen also showed great compliance among the patients.